On-Demand Webcast: Pharmacogenetics: A Critical Supplement to your Mental Health Strategy


Date and Time

Starts:05/17/2017 12:00 AM

Ends:05/18/2056 11:30 PM

Registration Closes:05/18/2056 4:00 AM

Event Type: Webinar

1 Hour Hour(s)

Price:

HRPA Members:
Complimentary
Non-Members:
$65 + Taxes
Join HRPA Now

Availability

Additional Information

Event Sponsor


Almost half of all prescription medications actually end up failing. When this happens, employees go through a lengthy trial-and-error period to find the right medication – and that can lead to absenteeism, disability claims, presenteeism, and drug waste.

Pharmacogenetic testing is designed to determine the right dose of the right drug the first time, eliminating the trial-and-error period and resulting in a better health outcome for your employees and their dependents.

Learn why your organization's mental health strategy is incomplete without pharmacogenetics, a cutting-edge new technology that can improve productivity and reduce mental illness-related absenteeism and disability. This webinar will address the basics of pharmacogenetics, as well as how to implement pharmacogenetics into your mental health program, and what you can expect in terms of return on investment.

 

Learning objectives:

  • Understand why pharmacogenetics is such a critical part of managing workplace mental illness
  • Learn what pharmacogenetics is and how can it be implemented into your benefits strategy to help contain costs and optimize employee health outcomes
  • Understand how introducing a pharmacogenetics program can help reduce disability claims, absenteeism, presenteeism and overall employee health and wellness costs

 

Who should attend?

This program is for senior-level HR professionals in Benefits and Total Rewards.

Speaker bio(s)
Michael Prouse, Director of Operations, Personalized Prescribing

Dr. Michael Prouse is the Director of Operations at Personalized Prescribing. After completing his Bachelor of Science at University of Toronto, Michael pursued his PhD in genetics, publishing several scientific papers on eukaryotic gene expression. Dr. Prouse finished at the top of his PhD class in 2013 and was the recipient of the Alexander Graham Bell Award for high-calibre scholars. Dr. Prouse brought his expertise in genetics to Personalized Prescribing in 2012 when he became a founding member of the company and employee number one.


Zahra Sakkejha, Director of Marketing, Personalized Prescribing

Zahra Sakkejha is the Director of Marketing at Personalized Prescribing. After completing her Bachelor of Science in Biology and Genetics at Western University, Zahra worked under Dr. Katherine Siminovitch in the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, sharing time between Dr. Siminovitch’s immunology research lab studying the genetic basis of rheumatoid arthritis and clinical genomics lab conducting genetic testing for clinical use. Zahra brought her clinical and research experience to Personalized Prescribing in 2013 when she became a founding member of the company and employee number two.